Abstract
Three immunoglobulin preparations for intravenous infusion were compared in vivo to determine their relative protective capacity against several gram-negative and gram-positive pathogens. Polyglobin N is a conventional IgG concentrate. Psomaglobin N is identical in formulation to Polyglobin N but is prepared from the plasma of donors who have naturally high levels of antibody to lipopolysaccharide antigens of Pseudomonas aeruginosa. IgGMA is a conventional IgG concentrate containing 12% IgG and 16% IgA. In a murine model of burn wound sepsis the three IgG preparations were similarly protective against three or ten strains of P. aeruginosa. Psomaglobin N and Polyglobin N were significantly (p less than or equal to 0.015) more protective than IgGMA against six of ten and three of ten strains of P. aeruginosa, respectively. In a murine model of Streptococcus pneumoniae type 3 pneumonia, the three Ig preparations were similarly protective. IgGMA was significantly more protective (p less than or equal to 0.025) than Psomaglobin N and Polyglobin N against Salmonella typhimurium in murine peritonitis. However, the mean protective dose (PD50) of the two later preparations was less than or equal to 20 mg/kg body weight. In models of peritonitis both Psomaglobin N and Polyglobin N were more protective than IgGMA (p less than or equal to 0.004) against Haemophilus influenzae b, Klebsiella pneumoniae, Serratia marcescens 06:H3 and group B Streptococcus types 1b and 1c. Psomaglobin N and ciprofloxacin were employed to treat established polymicrobial murine burn wound sepsis resulting from contamination of the burn site with mixtures of P. aeruginosa and Staphylococcus aureus.(ABSTRACT TRUNCATED AT 250 WORDS)
MeSH Terms
Animals
Bacterial Infections/therapy
Burns/therapy
Ciprofloxacin/therapeutic use
Combined Modality Therapy
Female
Immunoglobulin G/therapeutic use
Mice
Mice, Inbred Strains
Pseudomonas Infections/therapy
Pseudomonas aeruginosa/immunology
Staphylococcal Infections/therapy
Streptococcal Infections/therapy
Wound Infection/therapy
Chemicals
Immunoglobulin G
Ciprofloxacin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Collins M S
Hector R F
Roby R E
Edwards A A
Ladehoff D K
Dorsey J H
References (27)
27 references, click to expand
-
Evaluation of gamma globulin for prophylaxis against burn sepsis.
Surgery. 1965 Nov;58(5):810-4
PMID: 4158592
-
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5
PMID: 6721464
-
Comparative in vivo activity between intravenous immune globulin prepared by reduction and alkylation or by low pH.
J Infect Dis. 1985 Jun;151(6):1171-3
PMID: 3998515
-
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26
PMID: 6232895
-
Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
J Infect Dis. 1983 Jun;147(6):1090-8
PMID: 6406615
-
Burn wound infection.
J Trauma. 1981 Sep;21(9):753-6
PMID: 7277539
-
The gamma globulins. 3. The antibody deficiency syndromes.
N Engl J Med. 1966 Sep 29;275(13):709-15 contd
PMID: 5331313
-
Undegraded human immunoglobulin for intravenous use.
Vox Sang. 1975;28(6):422-37
PMID: 807036
-
Exotoxin production by clinical isolates of pseudomonas aeruginosa.
Infect Immun. 1977 Mar;15(3):776-80
PMID: 404244
-
Binding of protein A to some human gamma-globulins used intravenously.
Vox Sang. 1981;40(6):395-402
PMID: 6794221
-
A factor in human gamma globulin preparations active against Pseudomonas aeruginosa infect. in mice.
Proc Soc Exp Biol Med. 1957 Jan;94(1):214-7
PMID: 13400919
-
Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
Rev Infect Dis. 1986 Jul-Aug;8 Suppl 4:S426-33
PMID: 2944209
-
Replacement therapy with modified immunoglobulin G in burn patients: preliminary kinetic studies.
Am J Med. 1984 Mar 30;76(3A):175-80
PMID: 6424447
-
New immunotype schema for Pseudomonas aeruginosa based on protective antigens.
J Bacteriol. 1969 May;98(2):835-6
PMID: 4977486
-
Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
Infect Immun. 1983 Mar;39(3):1072-9
PMID: 6404817
-
Role of infection in mortality from severe burns. Evaluation of plasma, gamma-globulin, albumin and saline-solution therapy in a group of Peruvian children.
N Engl J Med. 1962 Aug 16;267:317-23
PMID: 14454824
-
Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection.
Infect Immun. 1979 Apr;24(1):181-7
PMID: 110690
-
Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.
Proc Natl Acad Sci U S A. 1985 Mar;82(6):1790-4
PMID: 3856860
-
Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
Am J Med. 1984 Mar 30;76(3A):168-74
PMID: 6424446
-
Studies on the immunotherapy of bacterial infections. I. The comparative effectiveness of human gamma-globulin against various bacterial species in mice.
J Immunol. 1958 Jul;81(1):29-31
PMID: 13563876
-
A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
J Infect Dis. 1977 Aug;136 Suppl:S181-5
PMID: 70492
-
Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice.
J Trauma. 1983 Jun;23(6):530-4
PMID: 6408266
-
[Properties and efficacy of a human immunoglobulin M preparation for intravenous administration].
Arzneimittelforschung. 1985;35(6):933-6
PMID: 4026919
-
Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera.
J Immunol. 1975 Jun;114(6):1779-84
PMID: 805178
-
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation.
Infect Immun. 1973 Aug;8(2):278-90
PMID: 4542033
-
Supportive therapy in burn care. An overview of infection control.
J Trauma. 1979 Nov;19(11 Suppl):879-80
PMID: 490712
-
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.
Antimicrob Agents Chemother. 1984 Nov;26(5):757-61
PMID: 6517559